Amalgamated Bank’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Amalgamated Bank’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,707	Closed	-$4K	–	3004
2024 Q2	$4K	Buy	+1,707	New	+$6.52K	﹤0.01%	2902
2022 Q2	–	Sell	-5,782	Closed	-$44K	–	3245
2022 Q1	$44K	Buy	+5,782	New	+$54.8K	﹤0.01%	2539

Amalgamated Bank's GTHX Position: Q3 2024 in Review

Amalgamated Bank sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 1,707 shares — an estimated $4K sold.

Amalgamated Bank first reported a position in GTHX in Q1 2022 and held it in 2 quarters. The position peaked at $44K in Q1 2022. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Amalgamated Bank reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Amalgamated Bank sold 1,707 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $4K.
Amalgamated Bank first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Amalgamated Bank's G1 Therapeutics, Inc. Common Stock position peaked at $44K in Q1 2022.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Amalgamated Bank's 13F filing for Q3 2024, filed 30 Oct 2024.